PNC Financial Services Group
STOK icon

PNC Financial Services Group’s Stoke Therapeutics STOK Stock Holding History

PNC Financial Services Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44K Hold
44
– – ﹤0.01% 4763
2026
Q1 		$1.43K Hold
44
– – ﹤0.01% 4673
2025
Q4 		$1.4K Hold
44
– – ﹤0.01% 4615
2025
Q3 		$1.03K Hold
44
– – ﹤0.01% 4670
2025
Q2 		$499 Hold
44
– – ﹤0.01% 4686
2025
Q1 		$293 Buy
44
+34
+340% +$317 ﹤0.01% 4731
2024
Q4 		$110 Hold
10
– – ﹤0.01% 4704
2024
Q3 		$123 Hold
10
– – ﹤0.01% 4713
2024
Q2 		$135 Buy
10
+5
+100% +$68 ﹤0.01% 4704
2024
Q1 		$68 Hold
5
– – ﹤0.01% 4657
2023
Q4 		$26 Buy
+5
New +$21 ﹤0.01% 4593

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PNC Financial Services Group's STOK Position: Q2 2026 in Review

PNC Financial Services Group held its Stoke Therapeutics (STOK) position steady in Q2 2026 at 44 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #4763.

PNC Financial Services Group first reported a position in STOK in Q4 2023 and has held it in 11 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • PNC Financial Services Group held 44 shares of Stoke Therapeutics worth $1.44K as of Q2 2026.
  • PNC Financial Services Group left its Stoke Therapeutics share count unchanged in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4763 holding.
  • PNC Financial Services Group first reported a position in Stoke Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.